Ir a las Transacciones
Private Equity | Salud

Gilde Healthcare has invested in Tandarts Today

Gilde Healthcare has invested in Tandarts Today, a fast-growing dental chain in the Netherlands. The investment will allow Tandarts Today to accelerate its buy-and-build strategy and become a leading dental chain in the Netherlands. Financial details have not been disclosed.

Tandarts Today, founded in 2015, offers all disciplines of regular dentistry, including special treatments such as implantology, orthodontics, periodontology and aesthetic treatments. Furthermore, through its own dental laboratories, it develops hockey bits, custom-made prostheses, bridges and other dental work pieces.

Gilde Healthcare is a specialized European healthcare investor managing over US$1.5 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in health tech and therapeutics. The venture & growth companies are based in Europe and North America. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies, with a focus on the Benelux and DACH regions. The private equity fund targets healthcare, suppliers of medical products and service providers in the healthcare market.

Oaklins’ team in the Netherlands acted as the exclusive financial advisor to the seller in this transaction.

Partes
“I am delighted to welcome Gilde Healthcare as a shareholder in Tandarts Today. Their experience in buy-and-build strategies combined with their healthcare angle and focus makes Gilde Healthcare the perfect partner to realize Tandarts Today’s growth objectives. Oaklins played a fundamental role in identifying Gilde Healthcare as a buyer and realizing the transaction in a dedicated and professional manner.”

Ruben Hoefnagels

Founder and CEO, Tandarts Today

Contáctese con el equipo de la transacción

Adse de Kock

Socio
Amsterdam, Países Bajos
Oaklins Netherlands

Sander van 't Spijker

Asociado Director
Amsterdam, Países Bajos
Oaklins Netherlands

Transacciones relacionadas

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Salud

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Conozca más
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Private Equity | Servicios de Soporte Comercial | Servicios de Construcción e Ingeniería

Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth

Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.

Conozca más
Nuzoa has acquired Agrofauna
Private Equity | Consumo & Retail

Nuzoa has acquired Agrofauna

Nuzoa, a provider of value-added services for pets and livestock in the Iberian Peninsula, has acquired 100% of Agrofauna. This transaction reinforces Nuzoa’s presence in the Portuguese market, particularly in the northern region, marking another step toward its ambition to become the leading operator while further consolidating its brand across Iberia.

Conozca más